肺炎支原体的耐药状况及中医药研究进展  

Mycoplasma pneumoniae resistance and advances in traditional Chinese medicine

作　　者：姚凤莉[1] 常凤媛[1] 于雅彬(综述)[1] 罗分平(审校)[1] 

机构地区：[1]北京军区总医院附属八一儿童医院儿童内科,100700

出　　处：《国际儿科学杂志》2011年第2期191-194,F0003,共5页International Journal of Pediatrics

摘　　要：肺炎支原体（mycoplasma pneumoniae，MP）是儿童呼吸道感染的常见病原体，大环内酯类抗生素是治疗小儿MP感染的首选药物。近年来MP对大环内酯类抗生素出现耐药，中医药治疗该病有较大优势。该文就MP的国内外耐药状况及中医药治疗小儿MP的优势、机制研究方面作一概述。Mycoplasma pneumoniae is a common pathogen of respiratory infection. Maerolides antibiotic is the first drug in treating children mycoplasma pneumoniae. Restently Mycoplasma pneumoniae shows resistance to maerolides antibiotic. Traditional Chinese medicine has more advantages in it. The paper summarizes drug resistance of mycoplasma pneumoniae and mechanisms research of traditional Chinese medicine.

关 键 词：肺炎支原体 大环内酯类 耐药 中医药 

分 类 号：R725.6[医药卫生—儿科]